LS

Lalita Sharma

Active Director Director DIN 10328859
DIN 10328859 First appointment Sep 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value •••• Premium profile

About Lalita Sharma

Data last updated:

Lalita Sharma is a Director at Mishka Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Mishka Pharmaceuticals Private Limited reported revenue of ₹1.5 Lakh (FY 2023).

DIN 10328859
Primary Designation Director
Industry Pharma
First Appointment 19 Sep 2023
Oldest Company Age 4 yrs
Largest company Mishka Pharmaceuticals Private Limited · ₹1.5 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Sep 20232021₹1.5 Lakh (FY 2023)Active

Board colleagues of Lalita Sharma

Directorship timeline

Open interactive timeline →
Mishka Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Lalita Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lalita Sharma

Lalita Sharma currently holds 1 directorship: Mishka Pharmaceuticals Private Limited (Director, since 19 Sep 2023, revenue ₹1.5 Lakh (FY 2023)).

Lalita Sharma was first appointed on 19 Sep 2023 as Director at Mishka Pharmaceuticals Private Limited.

The current boards of Lalita Sharma's companies include Jaya Sharma (Mishka Pharmaceuticals Private Limited), Prashant Sharma (Mishka Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available